Cancer Care during the COVID-19 Pandemic: Challenges and Adaptations
Conflicts of Interest
References
- Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727–733. [Google Scholar] [CrossRef] [PubMed]
- John Hopkin Coronavirus Resources Center. Available online: https://coronavirus.jhu.edu/map.html (accessed on 24 October 2022).
- Liang, W.; Guan, W.; Chen, R.; Wang, W.; Li, J.; Xu, K.; Li, C.; Ai, Q.; Lu, W.; Liang, H.; et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020, 21, 335–337. [Google Scholar] [CrossRef] [PubMed]
- Dai, M.; Liu, D.; Liu, M.; Zhou, F.; Li, G.; Chen, Z.; Zhang, Z.; You, H.; Wu, M.; Zheng, Q.; et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020, 10, 783–791. [Google Scholar] [CrossRef]
- Kuderer, N.M.; Choueiri, T.K.; Shah, D.P.; Shyr, Y.; Rubinstein, S.M.; Rivera, D.R.; Shete, S.; Hsu, C.Y.; Desai, A.; de Lopes, G.L., Jr.; et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet 2020, 395, 1907–1918. [Google Scholar] [CrossRef] [PubMed]
- Horn, L.; Whisenant, J.G.; Torri, V.; Huang, L.-C.; Trama, A.; Paz-Ares, L.G.; Felip, E.; Pancaldi, V.; De Toma, A.; Tiseo, M.; et al. Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival. J. Clin. Oncol. 2020, 38, LBA111. [Google Scholar] [CrossRef]
- Venkatesulu, B.P.; Chandrasekar, V.T.; Girdhar, P.; Advani, P.; Sharma, A.; Elumalai, T.; Hsieh, C.E.; Elghazawy, H.I.; Verma, V.; Krishnan, S. A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus. JNCI Cancer Spectr. 2021, 5, pkaa102. [Google Scholar] [CrossRef] [PubMed]
- Fendler, A.; de Vries, E.G.E.; GeurtsvanKessel, C.H.; Haanen, J.B.; Wörmann, B.; Turajlic, S.; von Lilienfeld-Toal, M. COVID-19 vaccines in patients with cancer: Immunogenicity, efficacy and safety. Nat. Rev. Clin. Oncol. 2022, 19, 385–401. [Google Scholar] [CrossRef] [PubMed]
- Gentile, I.; Moriello, N.S. COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination. PLoS Med. 2022, 19, e1003917. [Google Scholar] [CrossRef] [PubMed]
- Riera, R.; Bagattini, Â.M.; Pacheco, R.L.; Pachito, D.V.; Roitberg, F.; Ilbawi, A. Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review. JCO Glob. Oncol. 2021, 7, 311–323. [Google Scholar] [CrossRef] [PubMed]
- Nyk, Ł.; Kamecki, H.; Zagożdżon, B.; Tokarczyk, A.; Baranek, P.; Mielczarek, Ł.; Kryst, P.; Poletajew, S.; Sosnowski, R.; Szempliński, S. The Impact of the Ongoing COVID-19 Epidemic on the Increasing Risk of Adverse Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy. Curr. Oncol. 2022, 29, 2768–2775. [Google Scholar] [CrossRef] [PubMed]
- Jones, B.M.; Lehrer, E.J.; Saraf, A.; Shafaee, Z.; Salgado, L.R.; Osborn, V.W. Healthcare Disparities and Outcomes of Cancer Patients in a Community Setting from a COVID-19 Epicenter. Curr. Oncol. 2022, 29, 1150–1162. [Google Scholar] [CrossRef] [PubMed]
- Habermann, F.O.J.; Schmitt, D.; Failing, T.; Fischer, J.; Ziegler, D.A.; Fischer, L.A.; Alt, N.J.; Muster, J.; Donath, S.; Hille, A.; et al. Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes. Curr. Oncol. 2022, 29, 1080–1092. [Google Scholar] [CrossRef] [PubMed]
- Mangesius, J.; Arnold, C.R.; Seppi, T.; Mangesius, S.; Brüggl, M.; Eichberger, P.; Ganswindt, U. Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Curr. Oncol. 2021, 28, 4776–4785. [Google Scholar] [CrossRef] [PubMed]
- Di Lalla, V.; Patrick, H.; Siriani-Ayoub, N.; Kildea, J.; Hijal, T.; Alfieri, J. Satisfaction among Cancer Patients Undergoing Radiotherapy during the COVID-19 Pandemic: An Institutional Experience. Curr. Oncol. 2021, 28, 1507–1517. [Google Scholar] [CrossRef] [PubMed]
- Sundquist, S.; Kato, D.; Xu, R.Y.; Schoales, J.; Kulendran, S.; Dancey, J.E. The Impact of COVID-19 on Academic Cancer Clinical Trials in Canada and the Initial Response from Cancer Centers. Curr. Oncol. 2022, 29, 2435–2441. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ahmed, S. Cancer Care during the COVID-19 Pandemic: Challenges and Adaptations. Curr. Oncol. 2023, 30, 45-47. https://doi.org/10.3390/curroncol30010004
Ahmed S. Cancer Care during the COVID-19 Pandemic: Challenges and Adaptations. Current Oncology. 2023; 30(1):45-47. https://doi.org/10.3390/curroncol30010004
Chicago/Turabian StyleAhmed, Shahid. 2023. "Cancer Care during the COVID-19 Pandemic: Challenges and Adaptations" Current Oncology 30, no. 1: 45-47. https://doi.org/10.3390/curroncol30010004
APA StyleAhmed, S. (2023). Cancer Care during the COVID-19 Pandemic: Challenges and Adaptations. Current Oncology, 30(1), 45-47. https://doi.org/10.3390/curroncol30010004